Helicobacter pylori-induced thrombocytosis clinically indistinguishable from essential thrombocythemia

Leukemia and Lymphoma

Volumn 53, Issue 7, 2012, Pages 1423-1424

  Kawamata, Toyotaka ^a   Tojo, Arinobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; CLARITHROMYCIN; HYDROXYUREA; IMMUNOGLOBULIN G; INTERLEUKIN 6; LANSOPRAZOLE; LEVOTHYROXINE; RANIMUSTINE; THROMBOPOIETIN;

AGED; AUTOIMMUNE DISEASE; BONE MARROW; CASE REPORT; CHRONIC INFLAMMATION; DYSPEPSIA; ERADICATION THERAPY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HASHIMOTO DISEASE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HORMONE SUBSTITUTION; HUMAN; LETTER; MEGAKARYOCYTE; PRIORITY JOURNAL; SJOEGREN SYNDROME; SKIN ULCER; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOCYTOSIS;

AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; THROMBOCYTHEMIA, ESSENTIAL; THROMBOCYTOSIS;

EID: 84862748817     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.653787     Document Type: Letter

References (11)

1. Torgano G, Mandelli C, Massaro P, et al. Gastroduodenal lesions in polycythaemia vera: frequency and role of Helicobacter pylori. Br J Haematol 2002;117:198-202. (Pubitemid 34304443)
2. Karaoglu AO, Kadikoylu G, Yukselen V, et al. Gastrointestinal lesions and Helicobacter pylori in patients with myeloproliferative disorders. Saudi Med J 2004;25:1913-1916. (Pubitemid 40253667)
3. Gasbarrini A, Franceschi F, Tartaglione R, et al. Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 1998;352:878. (Pubitemid 28416725)
4. Takahashi T, Yujiri T, Shinohara K, et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br J Haematol 2004;124:91-96.
5. Bai Y, Wang Z, Bai X, et al. Cross-reaction of antibody against Helicobacter pylori urease B with platelet glycoprotein IIIa and its significance in the pathogenesis of immune thrombocytopenic purpura. Int J Hematol 2009;89:142-149.
6. Asahi A, Nishimoto T, Okazaki Y, et al. Helicobacter pylori eradication shifts monocyte Fcgamma receptor balance toward inhibitory FcgammaRIIB in immune thrombocytopenic purpura patients. J Clin Invest 2008;118:2939-2949.
7. Matsukawa Y, Kato K, Hatta Y, et al. Helicobacter pylori eradication reduces platelet count in patients without idiopathic thrombocytopenic purpura. Platelets 2007;18:52-55.
8. Matsukawa Y, Iwamoto M, Kato K, et al. Long term changes in platelet counts after H. pylori eradication in non-ITP patients. Platelets 2010;21:628-631.
9. Gobert AP, Bambou JC, Werts C, et al. Helicobacter pylori heat shock protein 60 mediates interleukin-6 production by macrophages via a toll-like receptor (TLR)-2-, TLR-4-, and myeloid differentiation factor 88-independent mechanism. J Biol Chem 2004;279:245-250. (Pubitemid 38044821)
10. Kaser A, Brandacher G, Steurer W, et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 2001;98:2720-2725.
11. Vainchenker W, Delhommeau F, Constantinescu SN, et al. New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011;118:1723-1735.